Važnost MR-a u određivanju stadija raka vrata maternice

Autor(i)

  • Marijana Hrga University of Split, University Department of Health Studies, Split, Croatia Autor
  • Tatjana Matijaš University of Split, University Department of Health Studies, Split, Croatia Autor

DOI:

https://doi.org/10.55378/rv.48.2.4

Ključne riječi:

FIGO stadij, karcinom vrata maternice, magnetska rezonancija, PET/CT, UZV

Sažetak

Rak vrata maternice jedan je od najčešćih malignih tumora koji pogađa žene. Kod bolesnica s ranim stadijem raka vrata maternice i lokalno uznapredovalim rakom vrata maternice princip liječenja je konvencionalan uključujući operaciju, kemoterapiju i radioterapiju, dok kod bolesnica s metastatskim rakom vrata maternice, ne postoji standardno liječenje zbog njegovih heterogenih manifestacija. Zbog svega toga ključno je na vrijeme dijagnosticirati i odrediti stadij karcinoma u svrhu kvalitete života. Snimanje tijekom primarne dijagnostičke obrade ključno je za točnu procjenu proširenosti tumora i metastatske bolesti kao i za odabir najbolje terapijske opcije, a pomoću FIGO sustava njegova je uloga dodatno naglašena. U odnosu na druge tehnike snimanja, MR nam pruža detaljne informacije o lokalizaciji i veličini tumora, invaziji u okolna tkiva, te prisutnost udaljenih metastaza. MR doprinosi individualiziranom pristupu u odabiru terapije, uzimajući u obzir specifične karakteristike tumora. Integracija MR-a u dijagnostički i terapijski proces poboljšava kliničke ishode pacijenata s karcinomom vrata maternice, omogućujući učinkovitu skrb. MR se nadopunjuje sa ostalim modalitetima snimanja kod dijagnostike i planiranja liječenja, te bez MR-a nije moguće utvrditi stadij bolesti i postaviti konačnu dijagnozu.

Reference

Haldorsen IS, Lura N, Blaakær J, Fischerova D, Werner HMJ. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer? Curr Oncol Rep. 2019 Jul 29;21(9):77. doi: 10.1007/s11912-019-0824-0.

Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer. 2018 Sep;42(5):457-465. doi: 10.1016/j.curr probl cancer.2018.06.003.

Boban A. STOP raku vrata maternice. Zavod za javno zdravstvo Dubrovačko-neretvanske županije (Pristupljeno 02.05.2024.). Available at: https://www.zzjzdnz.hr/hr/zdravlje/prevencija-raka/454

Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, Bothou A, Galazios G. Cervical cancer: screening, diagnosis and staging. J BUON. 2016 Mar-Apr;21(2):320-5. PMID: 27273940.

Džono Boban A. Epidemiologija raka vrata. Hrvatski zavod za javno zdravstvo (Pristupljeno 03.05.2024.). Available at: https://www.hzjz.hr/aktualnosti/epidemiologija-raka-vrata-maternice/

Olusola P, Banerjee HN, Philley JV, Dasgupta S. Human Papilloma Virus-Associated Cervical Cancer and Health Disparities. Cells. 2019 Jun 21;8(6):622. doi: 10.3390/cells8060622.

Nacionalni program ranog otkrivanja raka vrata maternice. Hrvatski zavod za javno zdravstvo (Pristupljeno 04.05.2024.). Available at: https://necurak.hzjz.hr/za-zene/rak-vrata-maternice/

Li H, Wu X, Cheng X. Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol. 2016 Jul;27(4):e43. doi: 10.3802/jgo.2016.27.e43.

Mello V, Sundstrom RK. Cervical Intraepithelial Neoplasia. 2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31335091.

Matsuo K, Machida H, Mandelbaum RS, Konishi I, Mikami M. Validation of the 2018 FIGO cervical cancer staging system. Gynecol Oncol. 2019 Jan;152(1):87-93. doi: 10.1016/j.ygyno.2018.10.026.

Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019 Apr;145(1):129-135. doi: 10.1002/ijgo.12749

Paramasivam S, Proietto A, Puvaneswary M. Pelvic anatomy and MRI. Best Pract Res Clin Obstet Gynaecol. 2006 Feb;20(1):3-22. doi: 10.1016/j.bpobgyn.2005.09.001.

McCarthy S, Vaquero E. Gynecologic anatomy with magnetic resonance imaging. Am J Obstet Gynecol. 1986 Aug;155(2):255-9. doi: 10.1016/0002-9378(86)90801-x.

Krmpotić-Nemanić, J.; Marušić, A. Anatomija čovjeka, Medicinska naklada, Zagreb, 2007.

The Global Academy of Women’s Medicine. The international federation of gynecology and obstetrics (Pristupljeno 10.05.2024.).Available at: https://www.glowm.com/sectionview/heading/Magnetic%20Resonance%20Imaging%20in%20Gynecology/item/67#

Nougaret S., Lambregts D. and Bruining A. Cervical Cancer – MR staging. Radiology Assistant (Pristupljeno 11.05.2024). Available at: https://radiologyassistant.nl/abdomen/unsorted/mr-in-cervical-cancer-1

Devine C, Viswanathan C, Faria S, Marcal L, Sagebiel TL. Imaging and Staging of Cervical Cancer. Semin Ultrasound CT MR. 2019 Aug;40(4):280-286. doi: 10.1053/j.sult.2019.03.001.

Haldorsen IS, Lura N, Blaakær J, Fischerova D, Werner HMJ. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer? Curr Oncol Rep. 2019 Jul 29;21(9):77. doi: 10.1007/s11912-019-0824-0

Engin G. Cervical cancer: MR imaging findings before, during, and after radiation therapy. Eur Radiol. 2006 Feb;16(2):313-24. doi: 10.1007/s00330-005-2804-z.

Matani H, Patel AK, Horne ZD, Beriwal S. Utilization of functional MRI in the diagnosis and management of cervical cancer. Front Oncol. 2022 Nov 11;12:1030967. doi: 10.3389/fonc.2022.1030967.

Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology. 1988 Mar;166(3):623-31. doi: 10.1148/radiology.166.3.3340756.

Downey K, Riches SF, Morgan VA, Giles SL, Attygalle AD, Ind TE, Barton DP, Shepherd JH, deSouza NM. Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. AJR Am J Roentgenol. 2013 Feb;200(2):314-20. doi: 10.2214/AJR.12.9545.

Downey K, Attygalle AD, Morgan VA, Giles SL, MacDonald A, Davis M, Ind TE, Shepherd JH, deSouza NM. Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer. Eur Radiol. 2016 Apr;26(4):941-50. doi: 10.1007/s00330-015-3899-5.

Manfredi R, Gui B, Giovanzana A, Marini S, Di Stefano M, Zannoni G, Scambia G, Bonomo L. Localized cervical cancer (stage

Otero-García MM, Mesa-Álvarez A, Nikolic O, Blanco-Lobato P, Basta-Nikolic M, de Llano-Ortega RM, Paredes-Velázquez L, Nikolic N, Szewczyk-Bieda M. Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers. Insights Imaging. 2019 Feb 13;10(1):19. doi: 10.1186/s13244-019-0696-8.

He M, Guo M, Zhou Q, Tang Y, Zhong L, Liu Q, et al. Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103). J Gynecol Oncol. 2023 May;34(3):e55. doi: 10.3802/jgo.2023.34.e55.

Bourgioti C, Chatoupis K, Moulopoulos LA. Current imaging strategies for the evaluation of uterine cervical cancer. World J Radiol. 2016 Apr 28;8(4):342-54. doi: 10.4329/wjr.v8.i4.342.

Holm J, Gerke O, Vilstrup MH, Spasojevic D, Sponholtz SE, Jochumsen KM, Thomassen A, Hildebrandt MG, Jensen PT. Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification. Gynecol Oncol. 2022 Nov;167(2):152-158. doi: 10.1016/j.ygyno.2022.09.021.

Hricak H, Lacey CG, Sandles LG, Chang YCF, Winkler ML, Stern JL. Invasive cervical carcinoma: Comparison of MR imaging and surgical findings. Radiology. 1988.;166(3):623–31.

Wu F, Zhang R, Li F, Qin X, Xing H, Lv H, Li L, Ai T. Radiomics analysis based on multiparametric magnetic resonance imaging for differentiating early stage of cervical cancer. Front Med (Lausanne). 2024 Feb 2;11:1336640. doi: 10.3389/fmed.2024.1336640.

Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol. 2003 Oct;91(1):59-66. doi: 10.1016/s0090-8258(03)00409-8.

Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009 May;105(2):103-4. doi: 10.1016/j.ijgo.2009.02.012.

Manganaro L, Lakhman Y, Bharwani N, Gui B, Gigli S, Vinci V, et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur Radiol. 2021 Oct;31(10):7802-7816. doi: 10.1007/s00330-020-07632-9.

Gala FB, Gala KB, Gala BM. Magnetic Resonance Imaging of Uterine Cervix: A Pictorial Essay. Indian J Radiol Imaging. 2021 Apr;31(2):454-467. doi: 10.1055/s-0041-1734377.

Salib MY, Russell JHB, Stewart VR, Sudderuddin SA, Barwick TD, Rockall AG, Bharwani N. 2018 FIGO Staging Classification for Cervical Cancer: Added Benefits of Imaging. Radiographics. 2020 Oct;40(6):1807-1822. doi: 10.1148/rg.2020200013.

Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology. 2013 Mar;266(3):717-40. doi: 10.1148/radiol.12120315.

Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology. 2013 Mar;266(3):717-40. doi: 10.1148/radiol.12120315.

Baliyan V, Das CJ, Sharma R, Gupta AK. Diffusion weighted imaging: Technique and applications. World J Radiol. 2016 Sep 28;8(9):785-798. doi: 10.4329/wjr.v8.i9.785.

Nougaret S, Tirumani SH, Addley H, Pandey H, Sala E, Reinhold C. Pearls and pitfalls in MRI of gynecologic malignancy with diffusion-weighted technique. AJR Am J Roentgenol. 2013 Feb;200(2):261-76. doi: 10.2214/AJR.12.9713.

Keshavarz E, Ahangaran A, Pouya EK, Maheronnaghsh R, Chavoshi M, Rouzrokh P. Effects of Obesity on Axillary Lymph Node Structure: Association of Hilar Fat Deposition and Alterations in Cortex Width. Maedica (Bucur). 2020 Mar;15(1):99-104. doi: 10.26574/maedica.2020.15.1.99.

Avesani G, Perazzolo A, Amerighi A, Celli V, Panico C, Sala E, Gui B. The Utility of Contrast-Enhanced Magnetic Resonance Imaging in Uterine Cervical Cancer: A Systematic Review. Life (Basel). 2023 Jun 12;13(6):1368. doi: 10.3390/life13061368.

Akita A, Shinmoto H, Hayashi S, Akita H, Fujii T, Mikami S, et al. Comparison of T2-weighted and contrast-enhanced T1-weighted MR imaging at 1.5 T for assessing the local extent of cervical carcinoma. Eur Radiol. 2011 Sep;21(9):1850-7. doi: 10.1007/s00330-011-2122-6.

McEvoy SH, Nougaret S, Abu-Rustum NR, Vargas HA, Sadowski EA, Menias CO, et al. Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management. Abdom Radiol (NY). 2017 Oct;42(10):2488-2512. doi: 10.1007/s00261-017-1179-3.

Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. doi: 10.1002/ijgo.13865.

Ciulla S, Celli V, Aiello AA, Gigli S, Ninkova R, Miceli V, et al. Post treatment imaging in patients with local advanced cervical carcinoma. Front Oncol. 2022 Oct 27;12:1003930. doi: 10.3389/fonc.2022.1003930.

Bell DJ, Pannu HK. Radiological assessment of gynecologic malignancies. Obstet Gynecol Clin North Am. 2011 Mar;38(1):45-68, vii. doi: 10.1016/j.ogc.2011.02.003.

Herrera FG, Prior JO. The role of PET/CT in cervical cancer. Front Oncol. 2013 Feb 26;3:34. doi: 10.3389/fonc.2013.00034.

Tsunoda AT, Marnitz S, Soares Nunes J, Mattos de Cunha Andrade CE, Scapulatempo Neto C, Blohmer JU, et al. Incidence of Histologically Proven Pelvic and Para-Aortic Lymph Node Metastases and Rate of Upstaging in Patients with Locally Advanced Cervical Cancer: Results of a Prospective Randomized Trial. Oncology. 2017;92(4):213-220. doi: 10.1159/000453666.

Epstein E, Di Legge A, Måsbäck A, Lindqvist PG, Kannisto P, Testa AC. Sonographic characteristics of squamous cell cancer and adenocarcinoma of the uterine cervix. Ultrasound Obstet Gynecol. 2010 Oct;36(4):512-6. doi: 10.1002/uog.7638.

Salomon LJ, Bernard JP, Millischer AE, Sonigo P, Brunelle F, Boddaert N, Ville Y: MRI and ultrasound fusion imaging for prenatal diagnosis. Am J Obstet Gynecol 209: 148 e141-149, 2013.

Thomassin-Naggara I, Siles P, Balvay D, Cuenod CA, Carette MF, Bazot M. MR perfusion for pelvic female imaging. Diagn Interv Imaging. 2013 Dec;94(12):1291-8. doi: 10.1016/j.diii.2013.06.004.

Fischerova D, Cibula D, Stenhova H, Vondrichova H, Calda P, Zikan M, et al. Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. Int J Gynecol Cancer. 2008 Jul-Aug;18(4):766-72. doi: 10.1111/j.1525-1438.2007.01072.x.

Vidal Urbinati AM, Pino I, Iacobone AD, Radice D, Azzalini G, Guerrieri ME, et al. Vaginosonography versus MRI in Pre-Treatment Evaluation of Early-Stage Cervical Cancer: An Old Tool for a New Precision Approach? Diagnostics (Basel). 2022 Nov 22;12(12):2904. doi: 10.3390/diagnostics12122904.

Chiappa V, Di Legge A, Valentini AL, Gui B, Miccò M, Ludovisi M, et al. Agreement of two-dimensional and three-dimensional transvaginal ultrasound with magnetic resonance imaging in assessment of parametrial infiltration in cervical cancer. Ultrasound Obstet Gynecol. 2015 Apr;45(4):459-69. doi: 10.1002/uog.14637.

Testa AC, Ludovisi M, Manfredi R, Zannoni G, Gui B, Basso Da, et al. Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. Ultrasound Obstet Gynecol. 2009 Sep;34(3):335-44. doi: 10.1002/uog.7325.

Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer: a meta-analysis. JAMA. 1997; 278: 1091–1101.

Barwick TD, Taylor A, Rockall A. Functional imaging to predict tumor response in locally advanced cervical cancer. Curr Oncol Rep. 2013 Dec;15(6):549-58. doi: 10.1007/s11912-013-0344-2.

Kido A, Fujimoto K, Okada T, Togashi K. Advanced MRI in malignant neoplasms of the uterus. J Magn Reson Imaging. 2013 Feb;37(2):249-64. doi: 10.1002/jmri.23716.

Kitajima K, Suenaga Y, Ueno Y, Kanda T, Maeda T, Deguchi M, Ebina Y, Yamada H, Takahashi S, Sugimura K. Fusion of PET and MRI for staging of uterine cervical cancer: comparison with contrast-enhanced (18)F-FDG PET/CT and pelvic MRI. Clin Imaging. 2014 Jul-Aug;38(4):464-469. doi: 10.1016/j.clinimag.2014.02.006.

Kim SK, Choi HJ, Park SY, Lee HY, Seo SS, Yoo CW, et al. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. Eur J Cancer. 2009 Aug;45(12):2103-9. doi: 10.1016/j.ejca.2009.04.006.

Hrga M. Uloga MR-a u dijagnostici i zboru liječenja karcinoma vrata maternice (Završni rad). Split: Sveučilište u Splitu, Sveučilišni odjel zdravstvenih studija; 2024 (pristupljeno 10.9.2024.) Available at: https://repo.ozs.unist.hr/islandora/object/ozs%3A1671/datastream/PDF/view

COVER The importance of MRI in determining the stage of cervical cancer

Preuzimanja

Objavljeno

07.10.2024

Kako citirati

Hrga, Marijana, i Tatjana Matijaš. 2024. „Važnost MR-a U određivanju Stadija Raka Vrata Maternice“. Radiološki Vjesnik 48 (2): 21-32. https://doi.org/10.55378/rv.48.2.4.

Slični članci

11-20 od 45

Također možete Započni napredno pretraživanje sličnosti za ovaj članak.

Najčitaniji članci istog autora / istih autora

1 2 > >>